IP Library Granted Patent US 7,223,791
Granted Patent B2
US 7,223,791 · App. 10/481,033 · Granted May 29, 2007

Function regulator for retinoid relative receptor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,791
App. No.
10/481,033
Granted
May 29, 2007
Kind
B2
Abstract

The present invention provides a retinoid-related receptor (except retinoic acid receptors) function regulating agent comprising a compound represented by the formula: wherein one of R 1 and R 2 is an optionally substituted monocyclic aromatic hydrocarbon group or an optionally substituted monocyclic aromatic heterocyclic group containing one heteroatom, and the other is a hydrogen atom and the like; B is a 5- or 6-membered heterocycle (except 1,3-azole); A is an optionally substituted aromatic hydrocarbon group or an optionally substituted aromatic heterocyclic group; and R 3 is a hydrogen atom and the like, or a salt thereof, which is useful as an agent for the prophylaxis or treatment of diabetes mellitus, hyperlipidemia, impaired glucose tolerance or the like.

Claims (8)

1. A method for the treatment of obesity in a mammal, which comprises administering, to the mammal, a peroxisome proliferator-activated receptor transcriptional activity promoter which is non-binding to peroxisome proliferator-activated receptors, wherein the peroxisome proliferator-activated receptor transcriptional activity promoter is a compound represented by the formula:

wherein

one of R 1 and R 2

is an optionally substituted monocyclic aromatic hydrocarbon group or an optionally substituted monocyclic aromatic heterocyclic group containing one heteroatom, and the other is a hydrogen atom, a halogen atom or an optionally substituted hydrocarbon group;

B is a furan;

A is an optionally substituted phenyl group; and

R 3 is —OR 4 (R 4 is a hydrogen atom or an optionally substituted hydrocarbon group),

or a salt thereof.

Assignments (3)
CHANGE OF NAME Recorded Dec 7, 2006
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 018598/0340 →
CHANGE OF NAME Recorded Jun 2, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 018917/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2003
From: MAEKAWA, TSUYOSHI; KUNITOMO, JUN; ODAKA, HIROYUKI; KIMURA, HIROYUKI
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 015235/0834 →